Literature DB >> 23467880

Prevention of neointimal hyperplasia in balloon-injured rat carotid artery via small interference RNA mediated downregulation of osteopontin gene.

Jian Xu1, Yingxian Sun, Tairan Wang, Guinan Liu.   

Abstract

The aim of the present study was to take osteopontin (OPN) as molecular target to study its effects on injured intima model of carotid artery in rat using perivascular transfer of OPN-small interference RNA (siRNA). OPN mRNA in cultured VSMCs was quantified by real-time RT-PCR, and OPN-siRNA-002 was determined as the most sensitive sequence and used as transfected siRNA in the subsequent animal experiments. We established rat carotid arterial intima-injured model with balloon-injured method, and then perivascularly transfected OPN-siRNA-002 to study the role of OPN-siRNA in regulating several related genes including proliferating cell nuclear antigen (PCNA), transforming growth factor β1(TGF-β1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-14 (MMP-14), as well as its role in neointimal formation. OPN mRNA and protein decreased about 50 % with corresponding decrease in intima thickness after transfecting with specific OPN-siRNA-002 compared with Pluronic control group and OPN-SCR-siRNA group on each time point (n = 6, p < 0.001), and this inhibiting effects persisted up to 14 days after balloon injury. PCNA, TGF-β1, MMP-2, and MMP-14 mRNA and protein correlated directly with the respective levels of OPN, suggesting its functions via regulating these downstream factors (n = 6, p < 0.001). OPN may be a potential target gene in reducing the risk for arterial restenosis after vascular intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467880     DOI: 10.1007/s11010-012-1554-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.

Authors:  T G Hullinger; Q Pan; H L Viswanathan; M J Somerman
Journal:  Exp Cell Res       Date:  2001-01-01       Impact factor: 3.905

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Coronary stents: current status.

Authors:  Scot Garg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2010-08-31       Impact factor: 24.094

4.  Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin.

Authors:  Y Hu; Y Zou; H Dietrich; G Wick; Q Xu
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

5.  Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation.

Authors:  L Liaw; D M Lombardi; M M Almeida; S M Schwartz; D deBlois; C M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-01       Impact factor: 8.311

6.  Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process.

Authors:  Y Xie; S Nishi; S Iguchi; N Imai; M Sakatsume; A Saito; M Ikegame; N Iino; H Shimada; M Ueno; H Kawashima; M Arakawa; F Gejyo
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

7.  Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice.

Authors:  Jeffrey S Berman; David Serlin; Xinfang Li; Geoffrey Whitley; John Hayes; David C Rishikof; Dennis A Ricupero; Lucy Liaw; Margaret Goetschkes; Anthony W O'Regan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

8.  c-myc in vasculoproliferative disease.

Authors:  E R Edelman; M Simons; M G Sirois; R D Rosenberg
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

9.  Egr-1 upregulates OPN through direct binding to its promoter and OPN upregulates Egr-1 via the ERK pathway.

Authors:  Qi-Feng Liu; Hong-Wei Yu; Gui-Nan Liu
Journal:  Mol Cell Biochem       Date:  2009-06-26       Impact factor: 3.396

Review 10.  Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury.

Authors:  Razi Khan; Alex Agrotis; Alex Bobik
Journal:  Cardiovasc Res       Date:  2007-02-14       Impact factor: 10.787

View more
  6 in total

1.  Temporal regulation of venous extracellular matrix components during arteriovenous fistula maturation.

Authors:  Michael R Hall; Kota Yamamoto; Clinton D Protack; Masayuki Tsuneki; Go Kuwahara; Roland Assi; Kirstyn E Brownson; Hualong Bai; Joseph A Madri; Alan Dardik
Journal:  J Vasc Access       Date:  2014-09-08       Impact factor: 2.283

2.  Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes.

Authors:  Chong Cao; Xiaowei Ji; Xin Luo; Liangjun Zhong
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  α-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression.

Authors:  Min A Jang; Seung Jin Lee; Seung Eun Baek; So Youn Park; Young Whan Choi; Chi Dae Kim
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

Review 4.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

5.  The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway.

Authors:  Lianghu Tang; Haifeng Pei; Yi Yang; Xiong Wang; Ting Wang; Erhe Gao; De Li; Yongjian Yang; Dachun Yang
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

6.  BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway.

Authors:  Guangtong Deng; Furong Zeng; Juan Su; Shuang Zhao; Rui Hu; Wu Zhu; Shuo Hu; Xiang Chen; Mingzhu Yin
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.